e-learning
resources
Amsterdam 2011
Monday, 26.09.2011
Advances in antibiotic therapy of non-cystic fibrosis bronchiectasis
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Airways reflux contributes to cough severity and airways inflammation in non-CF bronchiectasis
P. Mandal, A. Morice, J. Chalmers, A. Hill (Edinburgh, Cottingham, United Kingdom)
Source:
Annual Congress 2011 - Advances in antibiotic therapy of non-cystic fibrosis bronchiectasis
Session:
Advances in antibiotic therapy of non-cystic fibrosis bronchiectasis
Session type:
Oral Presentation
Number:
1926
Disease area:
Airway diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Mandal, A. Morice, J. Chalmers, A. Hill (Edinburgh, Cottingham, United Kingdom). Airways reflux contributes to cough severity and airways inflammation in non-CF bronchiectasis. Eur Respir J 2011; 38: Suppl. 55, 1926
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Late Breaking Abstract - Efficacy of Breathox® device inhalation on acute symptoms associated with COVID-19 (BREATH study)
ERS statement for defining respiratory exacerbations in children and adolescents with bronchiectasis for clinical trials
Related content which might interest you:
Induced sputum and airway inflammation in asthma and COPD
Source: Annual Congress 2006 - PG14 - Noninvasive monitoring of asthma inflammation and treatment
Year: 2006
Neutrophilic inflammation in severe asthmatics and COPD patients with the same severity of airway obstruction
Source: Eur Respir J 2002; 20: Suppl. 38, 505s
Year: 2002
Airways mucus pathogenesis in patients with non-cystic fibrosis bronchiectasis
Source: International Congress 2018 – Biomarkers and lung function in airway disease
Year: 2018
Eosinophilic airway inflammation in COPD and asthma
Source: Annual Congress 2008 - Invasive and noninvasive measurements of lung inflammation
Year: 2008
Bronchial reversibility and airway inflammation in patients with COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 436s
Year: 2003
Clinical outcome of eosinophilic airway inflammation in chronic airway diseases including nonasthmatic eosinophilic bronchitis
Source: International Congress 2017 – Asthma and allergy: from the bench to the bedside
Year: 2017
Clinical and inflammatory determinants of bronchial hyperresponsiveness in COPD
Source: Eur Respir J 2012; 40: 1098-1105
Year: 2012
Airway inflammation in patients with chronic cough caused by gastroesophageal reflux
Source: International Congress 2017 – Best clinical practice for the management of chronic lung diseases
Year: 2017
Relationship between peripheral airway obstruction and airway inflammation in COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 509s
Year: 2006
Airway inflammation in severe asthmatics with gastro-oesophageal reflux
Source: International Congress 2017 – Diagnostic tools and comorbidities in paediatric asthma
Year: 2017
Bronchial vascularity in the airways of chronic bronchitis and COPD smokers
Source: Annual Congress 2010 - COPD and asthma: models and human studies
Year: 2010
Infection and bronchial obstruction in COPD exacerbation
Source: Eur Respir J 2003; 22: Suppl. 45, 417s
Year: 2003
Inflammatory mediators in eosinophilic COPD phenotype and asthma with fixed airflow obstruction
Source: International Congress 2018 – Understanding the immunopathology that underlies airway obstructive diseases
Year: 2018
Role of tissue kallikrein 1 in late phase bronchoconstriction and airway hyperresponsiveness
Source: Annual Congress 2006 - Basic mechanisms of allergic airways inflammation
Year: 2006
Characteristics of airway hyperresponsiveness and reversibility in asthma and chronic obstructive pulmonary disease
Source: Annual Congress 2008 - PG17 - An expert view of the differences between asthma and COPD
Year: 2008
Airway inflammation in COPD: physiological outcome measures and induced sputum
Source: Eur Respir J 2003; 21: 19S-28S
Year: 2003
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept